Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...

Even though cooler days may seem far off, now is the best time to plan ahead for a healthy winter. One common respiratory ...

Respiratory virus data included in the interactive data application is up-to-date as of September 14, 2024. Among its new features, the dashboard now includes RSV Severe Outcomes data.

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

You will be able to get a free RSV vaccination because you’re aged 75 to 79 years (or recently turned 80). Every year, thousands of people in your age group need hospital care for RSV infection. RSV ...

Respiratory virus season is right around the corner. Although rates are still nowhere close to where they were during 2022’s omicron wave, percent positivity remains high and was higher in late ...

NHS will roll out a one-time “catch-up” RSV vaccine campaign for individuals aged 75 to 79 years. Credit: MargJohnsonVA/Shutterstock. The UK National Health ...

People aged 75+ can now benefit from the UK’s rollout of a RSV vaccine to protect elderly people from the Respiratory Syncytial Virus (RSV). However, some people wonder what is RSV, the symptoms of ...

keeping you informed every step of the way to the November election From Sunday thousands across England and Scotland will be eligible to get a vaccine to protect them from respiratory syncytial ...